Standout Papers

Global Strategy for the Diagnosis, Ma... 1991 2026 2002 2014 9.2k
  1. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (2012)
    Jørgen Vestbo, Suzanne S. Hurd et al. American Journal of Respiratory and Critical Care Medicine
  2. A Self-complete Measure of Health Status for Chronic Airflow Limitation: The St. George's Respiratory Questionnaire (1992)
    Paul Jones, Frances Quirk et al. American Review of Respiratory Disease
  3. Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease (2007)
    Peter Calverley, Julie A. Anderson et al. New England Journal of Medicine
  4. Development and first validation of the COPD Assessment Test (2009)
    Paul Jones, Gale Harding et al. European Respiratory Journal
  5. The St George's Respiratory Questionnaire (1991)
    Paul Jones, Frances Quirk et al. Respiratory Medicine
  6. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease (1999)
    Janine Bestall, Elizabeth Paul et al. Thorax
  7. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial (2003)
    Peter M.A. Calverley, Romain Pauwels et al. The Lancet
  8. Chronic Obstructive Pulmonary Disease Phenotypes (2010)
    MeiLan K. Han, Àlvar Agustí et al. American Journal of Respiratory and Critical Care Medicine
  9. A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease (2002)
    Richard Casaburi, Donald A. Mahler et al. European Respiratory Journal
  10. St. George's Respiratory Questionnaire: MCID (2005)
    Paul Jones COPD Journal of Chronic Obstructive Pulmonary Disease
  11. Treatable traits: toward precision medicine of chronic airway diseases (2016)
    Àlvar Agustí, Elisabeth H. Bel et al. European Respiratory Journal
  12. Effect of Pharmacotherapy on Rate of Decline of Lung Function in Chronic Obstructive Pulmonary Disease (2008)
    Bartolomé R. Celli, Julie A. Anderson et al. American Journal of Respiratory and Critical Care Medicine
  13. Minimal Clinically Important Differences in Pharmacological Trials (2014)
    Paul Jones, Kai Michael Beeh et al. American Journal of Respiratory and Critical Care Medicine

Immediate Impact

156 standout
Sub-graph 1 of 10

Citing Papers

Three-year outcomes of post-acute sequelae of COVID-19
2024 Standout
Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation
2024 Standout
140 intermediate papers

Works of Paul Jones being referenced

Effect of Pharmacotherapy on Rate of Decline of Lung Function in Chronic Obstructive Pulmonary Disease
2008 Standout
St. George's Respiratory Questionnaire: MCID
2005 Standout
and 83 more

Author Peers

Author Last Decade Papers Cites
Paul Jones 34567 17320 1691 2935 289 39.0k
Jørgen Vestbo 39764 22149 1329 4273 494 48.1k
Bartolomé R. Celli 32913 15311 1157 2884 435 37.8k
Àlvar Agustí 33336 21167 995 3576 462 44.6k
Emiel F.�M. Wouters 25922 14145 677 3284 638 39.7k
Don D. Sin 23913 11988 618 2969 466 32.4k
Jadwiga A. Wedzicha 20837 9331 965 3256 204 23.8k
Leonardo M. Fabbri 26974 18453 549 3481 434 38.1k
Peter M.A. Calverley 22071 12765 790 1659 227 24.7k
A. Sonia Buist 17934 11155 599 1685 205 23.9k
David M. Mannino 17776 9855 707 6936 328 31.5k

All Works

Loading papers...

Rankless by CCL
2026